Ocular Therapeutix, Inc. (OCUL) has a market capitalization of $1.91B and trades at $8.76. The 52-week range is 5.8-16.44.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.2, Earnings Per Share (EPS) of $-1.42, annual revenue of $51.82M.
The stock has a beta of 0.95, operates in the Healthcare sector.
